A detailed history of Cva Family Office, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Cva Family Office, LLC holds 38 shares of TXG stock, worth $570. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38
Previous 23 65.22%
Holding current value
$570
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$15.71 - $23.49 $235 - $352
15 Added 65.22%
38 $0
Q2 2024

Jul 09, 2024

BUY
$19.45 - $37.37 $447 - $859
23 New
23 $0

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.43B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Cva Family Office, LLC Portfolio

Follow Cva Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cva Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cva Family Office, LLC with notifications on news.